Herrmann Ken bought AKTS
July 20, 2026 · Form 4 insider transaction
Herrmann Ken bought 1,350 shares of Aktis Oncology, Inc. at $1.91 per share, a transaction worth $2.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,350
Price
$1.91
Total value
$2.6K
InsiderHerrmann Ken
RoleDirector
CompanyAktis Oncology, Inc. (AKTS)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 20, 2026
Filing dateJuly 21, 2026
Shares owned after4,856
OwnershipDirect
10b5-1 planNo
AmendedNo